Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On
In accordance with Section 1007 of the Company Guide, the Company will have six
months from the date of the filing delinquency, or until
During the Initial Cure Period and the Additional Cure Period, if applicable,
the Company's securities will continue to trade on the Exchange, subject to the
Company's compliance with other continued listing requirements, with a late
filer (".LF") indicator. The Company can regain compliance with the Exchange's
continued listing standards at any time during the Initial Cure Period or
Additional Cure Period, as applicable, by filing the Form 10-Q and any
subsequent delayed filings with the
Cautionary Statement Regarding Forward-Looking Statements
Statements contained in this Current Report on Form 8-K that are not historical facts may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may relate to, among other things, the Company's expectations relating to the filing of the Form 10-K and the financial information to be included therein. Such forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties. The Company does not undertake any obligation to update forward-looking statements as a result of new information, future events or developments or otherwise, except as required by applicable law or regulation.
Item 7.01 Regulation FD Disclosure
On
In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Text of press release issuedMay 30, 2023 , byAir Industries Group . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
© Edgar Online, source